SPRY icon

ARS Pharmaceuticals

100 hedge funds and large institutions have $359M invested in ARS Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 30 increasing their positions, 29 reducing their positions, and 16 closing their positions.

Holders
100
Holders Change
+3
Holders Change %
+3.09%
% of All Funds
1.47%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
19
Increased
30
Reduced
29
Closed
16
Calls
$3.99M
Puts
$2.36M
Net Calls
+$1.64M
Net Calls Change
+$1.14M
Name Holding Trade Value Shares
Change
Shares
Change %
Millennium Management
101
Millennium Management
New York
-$4.15M -1,097,525 Closed
CC
102
Clearline Capital
New York
-$1.03M -271,678 Closed
Vontobel Holding
103
Vontobel Holding
Switzerland
-$985K -260,684 Closed
SCM
104
Soleus Capital Management
Connecticut
-$567K -150,000 Closed
VF
105
Virtu Financial
New York
-$305K -80,816 Closed
Bank of Montreal
106
Bank of Montreal
Ontario, Canada
-$97.5K -13,835 Closed
SG
107
StoneX Group
New York
-$42.6K -11,280 Closed
ASRS
108
Arizona State Retirement System
Arizona
-$40.8K -10,794 Closed
Teacher Retirement System of Texas
109
Teacher Retirement System of Texas
Texas
-$41K -10,760 Closed
DTL
110
Dynamic Technology Lab
Singapore
-$39K -10,371 Closed
XT
111
XTX Topco
Cayman Islands
-$38.2K -10,117 Closed
Corient Private Wealth
112
Corient Private Wealth
Florida
-$38K -10,042 Closed
Belvedere Trading
113
Belvedere Trading
Illinois
-$23.2K -6,143 Closed
Federated Hermes
114
Federated Hermes
Pennsylvania
-$2.67K -707 Closed
PA
115
Parallel Advisors
California
-$571 -151 Closed